Interview: Uğur Bingöl – Managing Director, Ibrahim Etem Menarini – Turkey
Menarini’s Turkish subsidiary, Ibrahim Etem Menarini, has adapted to the current pharmaceutical market and is…
Ibrahim Etem Menarini – Turkey
Last updated: 15.06.2015
The first established and the most prominent and innovative pharmaceutical company in Turkey.
Ibrahim Etem Ulugay, founded in 1903, was the first moder pharmaceutical manufacturer in Turkey and introduced modern scientific methodology to the pharmaceutical sector for the first time in Turkey. In 1955 the company became the first antibiotics manufacturer in Turkey, and in 2001 the Italian Menarini Group acquired this historical Turkish company. Today, Ibrahim Etem Menarini, as a member of Menarini Group, is a unique Italian-Turkish company operating in both innovative and generic markets.
Contact Details
Davutpaşa Cad. No: 12
34010 Topkapı – İstanbul
Telefon: 00 90 0212 467 11 11
Fax: 00 90 212 467 12 12
Interviews
Related
SeokHoon Kang – General Manager Turkey, Celltrion Healthcare
Best known as the company that launched the world’s first “antibody biosimilar,” Celltrion is looking to…
Evren Özlu – General Manager, Boehringer Ingelheim Turkey
Evren Özlü, General Manager of Turkey and Sub-Saharan Africa at Boehringer Ingelheim, discusses the company’s…
Ufuk Kumrulu – Chairman, Polifarma
Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu,…
Turkey / A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has…
Burak Dağlıoğlu – President, Investment Office of the Presidency of the…
The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines…
Muzzafer Bal – CEO, Ali Raif
Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a…
Turkey / Abdi Ibrahim CEO Talks Biosimilars, M&A, & US Entry
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…
Hatice Öncel – CEO, Ilko Pharmaceuticals
Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel…
Hamdi Akan – Head of the Executive Board, Clinical Research Association,…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and…
Ismail Yormaz – VP & Regional Director South-East, Recordati
Ismail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has…
Turkey / How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of…
Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey…
